AHA Scientific Sessions 2026 Abstract · Nov 2, 2026
Hypertensive Crisis Hospitalization as a Marker of Future Heart Failure, Atrial Fibrillation, and Major Adverse Cardiovascular Events
By Kim H, Guardia J, Tchillingirian S et al.
Introduction: Hypertensive crisis is usually managed as an acute blood pressure event, but may identify a population at increased downstream cardiovascular risk. Post-discharge screening for incident heart failure or atrial arrhythmia after hypertensive crisis remains poorly defined. Research Question: We evaluated whether hypertensive crisis hospitalization identifies a population at increased 3-year risk of incident HFpEF, HFrEF, atrial fibrillation/flutter, and MACE among hospitalized adults with hypertension and no prior heart failure or atrial fibrillation/flutter. Methods: A retrospective propensity-matched cohort study was performed using the Mount Sinai Health System TriNetX database. Index hospitalizations occurred from January 1, 2017 to January 1, 2023, allowing 3-year follow-up. Adults hospitalized with documented hypertension were classified as having hypertensive crisis, defined by ICD-10-CM I16, or as hospitalized hypertensive controls without documented crisis. Patients with heart failure or atrial fibrillation/flutter on or before index were excluded. Propensity score matching included demographics, comorbidities, BMI, hemoglobin A1c, healthcare utilization, and baseline cardiovascular and antihypertensive medications. All matched covariates had standardized mean differences <0.10. The primary outcome was incident HFpEF. Secondary outcomes included HFrEF, atrial fibrillation/flutter, and MACE (myocardial infarction, stroke, or all-cause mortality). Results: 1,570 hypertensive crisis patients and 28,610 controls were identified; after matching, 1,540 patients remained per group. Cohorts were similar in age (62.2±15.1 vs 61.8±15.3 years), female sex (51.3% vs 49.4%), White race (17.5% vs 17.5%), Black race (41.6% vs 42.2%), and Hispanic ethnicity (26.6% vs 26.0%). Hypertensive crisis was associated with higher observed 3-year risk of HFpEF (12.338% vs 3.896%; HR 3.538 [2.608-4.799]; p<0.0001), HFrEF (11.039% vs 3.896%; HR 2.640 [1.962-3.550]; p<0.0001), atrial fibrillation/flutter (7.143% vs 3.247%; HR 2.320 [1.638-3.287]; p<0.0001), and MACE (33.117% vs 22.078%; HR 1.572 [1.369-1.806]; p<0.0001). Conclusions: Hypertensive crisis hospitalization was associated with higher observed 3-year risk of incident HFpEF, HFrEF, atrial fibrillation/flutter, and MACE. The strongest relative association was observed for HFpEF, while MACE accounted for the largest absolute event burden. These hypothesis-generating findings suggest that hypertensive crisis may identify high-risk patients who could be considered for closer longitudinal cardiovascular surveillance beyond blood pressure management alone.